Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants

Journal of Virology

Volumn 77, Issue 3, 2003, Pages 2182-2194

  Streblow, Daniel N ^a   Kreklywich, Craig ^a,b   Yin, Qiang ^a,b   De La Melena, V T ^b   Corless, Christopher L ^a,b   Smith, Patricia A ^a   Brakebill, Christina ^b   Cook, Judith W ^b   Vink, Cornelis ^c   Bruggeman, Cathrien A ^c   Nelson, Jay A ^a   Orloff, Susan L ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL OCCLUSION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INFLAMMATORY CELL; INTESTINE GRAFT; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; CHEMOKINES; CHEMOKINES, C; CHEMOKINES, CX3C; CHEMOKINES, CXC; CHRONIC DISEASE; CYTOMEGALOVIRUS; GRAFT REJECTION; HEART TRANSPLANTATION; INTERFERON TYPE II; LYMPHOKINES; MALE; MEMBRANE PROTEINS; RATS; RATS, INBRED F344; SIALOGLYCOPROTEINS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; UP-REGULATION;

EID: 0037302362     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.3.2182-2194.2003     Document Type: Article

References (57)

1. Adler, S. P. 1983. Transfusion-associated cytomegalovirus infections. Rev. Infect. Dis. 5:977-993.
2. Armstrong, A. T., A. R. Strauch, R. C. Starling, D. D. Sedmak, and C. G. Orosz. 1997. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 63:941-947.
3. Ballard, R. A., W. L. Drew, K. G. Hufnagle, and P. A. Riedel. 1979. Acquired cytomegalovirus infection in preterm infants. Am. J. Dis. Child. 133:482-485.
4. Boehler, A., A. Schaffner, F. Salomon, and G. Keusch. 1994. Cytomegalovirus disease of late onset following renal transplantation: a potentially fatal entity. Scand. J. Infect. Dis. 26:369-373.
5. Bruggeman, C. A., H. Meijer, F. Bosman, and C. P. van Boven. 1985. Biology of rat cytomegalovirus infection. Intervirology 24:1-9.
6. Bruggeman, C. A., H. Schellekens, G. Grauls, W. M. Debie, and C. P. van Boven. 1983. Rat cytomegatovirus: induction of and sensitivity to interferon. Antivir. Res. 3:315-324.
7. Bruning, J. H., M. C. J. Persoons, K. B. Lemstrom, F. S. Stals, E. De Clercq, and C. A. Bruggeman. 1994. Enhancement of transplantation-associated atherosclerosis by CMV, which can be prevented by antiviral therapy in the form of HPMPC. Transplant. Int. 7(Suppl. 1):S365-S370.
8. Cheeran, M. C., S. Hu, S. L. Yager, G. Gekker, P. K. Peterson, and J. R. Lokensgard. 2001. Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications. J. Neurovirol. 7:135-147.
9. Einhorn, L, and A. Ost. 1984. Cytomegalovirus infection of human blood cells. J. Infect. Dis. 149:207-214.
10. Froberg, M. K., A. Adams, N. Seacotte, J. Parker-Thornburg, and P. Kolat-tukudy. 2001. Cytomegalovirus infection accelerates inflammation in vascular tissue overexpressing monocyte chemoattractant protein-1. Circ. Res. 89:1224-1230.
11. Gu, L., Y. Okada, S. K. Clinton, C. Gerard, G. K. Sukhova, P. Libby, and B. J. Rollins. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell 2:275-281.
12. Hancock, W. W., W. Gao, V. Csizmadia, K. L. Faia, N. Shemmeri, and A. D. Luster. 2001. Donor-derived IP-10 initiates development of acute allograft rejection. J. Exp. Med. 193:975-980.
13. Hancock, W. W., B. Lu, W. Gao, V. Csizmadia, K. Faia, J. A. King, S. T. Smiley, M. Ling, N. P. Gerard, and C. Gerard. 2000. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192:1515-1520.
14. Horuk, R. 2001. Chemokine receptors. Cytokine Growth Factor Rev. 12: 313-335.
15. Hosenpud, J. D., G. D. Shipley, and C. R. Wagner. 1992. Cardiac allograft vasculopathy: current concepts, recent developments and future directions. J. Heart Lung Transplant. 11:9-23.
16. Kondo, K., H. Kaneshima, and E. S. Mocarski. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. USA 91:11879-11883.
17. Kondo, K., J. Xu, and E. S. Mocarski. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. USA 93:11137-11142.
18. Kotenko, S. V., S. Saccani, L. S. Izotova, O. V. Mirochnitchenko, and S. Pestka. 2000. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). Proc. Natl. Acad. Sci. USA 97:1695-1700.
19. Lautenschlager, I., A. Soots, L. Krogerus, K. Inkinen, J. Kloover, R. Loginov, K. Holma, H. Kauppinen, C. Bruggeman, and J. Ahonen. 1999. Time-related effects of cytomegalovirus infection on the development of chronic renal allograft rejection in a rat model. Intervirology 42:279-284.
20. Lemstrom, K., J. Bruning, P. Koskinen, C. Bruggeman, I. Lautenschlager, and P. Hayry. 1994. Triple-drug immunosuppression significantly reduces chronic rejection in noninfected and RCMV-infected rats. Transpl. Proc. 26:1727-1728.
21. Lemstrom, K., P. Koskinen, L. Krogerus, M. Daemen, C. A. Bruggeman, and P. J. Hayry. 1995. Cytomegalovirus antigen expression, endothelial cell proliferation, and intimal thickening in rat cardiac allografts after cytomegalovirus infection. Circulation 92:2594-2604.
22. Lemstrom, K., R. Sihvola, C. Bruggeman, P. Hayry, and P. Koskinen. 1997. Cytomegalovirus infection-enhanced cardiac allograft vasculopathy is abolished by DHPG prophylaxis in the rat. Circulation 95:2614-2616.
23. Lemstrom, K. B., J. H. Bruning, C. A. Bruggeman, P. Koskinen, P. T. Aho, S. Yilmaz, I. T. Lautenschlager, and P. J. Hayry. 1994. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation 90:1969-1978.
24. Lemstrom, K. B., J. H. Bruning, C. A. Bruggeman, I. T. Lautenschlager, and P. J. Hayry. 1993. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J. Clin. Investig. 92:549-558.
25. Lemstrom, K. B., J. H. Bruning, C. A. Bruggeman, I. T. Lautenschlager, and P. J. Hayry. 1994. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Am. J. Pathol. 144:1334-1347.
26. Macher, A. M., C. M. Reichert, S. E. Straus, D. L. Longo, J. Parrillo, H. C. Lane, A. S. Fauci, A. H. Rook, J. F. Manischewitz, and G. V. Quinnan, Jr. 1983. Death in the AIDS patient: role of cytomegalovirus. N. Engl. J. Med. 309:1454.
27. Melnick, J. L., E. Adam, and M. E. DeBakery. 1998. The link between CMV and atherosclerosis. Infect. Med. 479-486.
28. Melnick, J. L., B. L. Petrie, G. R. Dreesman, J. Burek, C. H. McCollum, and M. E. DeBakey. 1983. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 644-647.
29. Melter, M., A. Exeni, M. E. Reinders, J. C. Fang, G. McMahon, P. Ganz, W. W. Hancock, and D. M. Briscoe. 2001. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 104:2558-2564.
30. Melter, M., G. McMahon, J. Fang, P. Ganz, and D. M. Briscoe. 1999. Current understanding of chemokine involvement in allograft transplantation. Pediatr. Transplant. 3:10-21.
31. Merigan, T. C., D. G. Renlund, S. Keay, et al. 1992. A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. N. Engl. J. Med. 326:1182-1186.
32. Michelsom, S., P. Dal Monte, D. Zipeto, B. Bodaghi, L. Laurent, E. Oberlin, F. Arenzana-Seisdedos, J. Virelizier, and M. P. Landini. 1997. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. J. Virol. 71:6495-6500.
33. Neiman, P., P. B. Wasserman, B. B. Wentworth, G. F. Kao, K. G. Lerner, R. Storb, C. D. Buckner, R. A. Clift, A. Fefer, L. Fass, H. Glucksberg, and E. D. Thomas. 1973. Interstitial pneumonia and cytomegalovirus infection as complications of human marrow transplantation. Transplantation 15:478-485.
34. Nelson, J. A., J. W. Gnann, Jr., and P. Ghazal. 1990. Regulation and tissue-specific expression of human cytomegalovirus. Curr. Top. Microbiol. Immunol. 154:75-100.
35. Nordoy, I., F. Muller, K. P. Nordal, H. Rollag, P. Aukrust, and S. S. Froland. 2000. Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection. Clin. Exp. Immunol. 120:333-337.
36. Orloff, S. L. 1999. Elimination of donor-specific alloreactivity by bone marrow chimerism prevents cytomegalovirus accelerated transplant vascular sclerosis in rat small bowel transplants. J. Clin. Virol. 12:G3-G25.
37. Orloff, S. L., D. N. Streblow, C. Soderberg-Naucler, Q. Yin, C. Kreklywich, C. L. Corless, P. A. Smith, C. B. Loomis, L. K. Mills, J. W. Cook, C. A. Bruggeman, J. A. Nelson, and C. R. Wagner. 2002. Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants. Transplantation 73:679-688.
38. Orloff, S. L., Q. Yin, C. L. Coreless, C. B. Loomis, J. M. Rabkin, and C. R. Wagner. 1999. A rat small bowel transplant model of chronic rejection: histopathologic characteristics. Transplantation 68:766-779.
39. Orloff, S. L., Q. Yin, C. L. Corless, M. S. Orloff, J. M. Rabkin, and C. R. Wagner. 2000. Tolerance induced by bone marrow chimerism prevents transplant vascular sclerosis in a rat model of small bowel transplant chronic rejection. Transplantation 69:1295-1303.
40. Redman, T. K., W. J. Britt, C. M. Wilcox, M. F. Graham, and P. D. Smith. 2002. Human cytomegalovirus enhances chemokine production by lipopolysaccharide-stimulated lamina propria macrophages. J. Infect. Dis. 185:584-590.
41. Robinson, L. A., C. Nataraj, D. W. Thomas, D. N. Howell, R. Griffiths, V. Bautch, D. D. Patel, L. Feng, and T. M. Coffman. 2000. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection. J. Immunol. 165:6067-6072.
42. Rott, D., J. Zhu, M. S. Burnett, Y. F. Zhou, A. Wasserman, J. Walker, and S. E. Epstein. 2001. Serum of cytomegalovirus-infected mice induces monocyte chemoattractant protein-1 expression by endothelial cells. J. Infect. Dis. 184:1109-1113.
43. Russel, M. E., W. W. Hancock, A. F. Wallace, L. R. Wyner, and M. J. Karnovsky. 1995. Modulation of inflammatory activation pathways in the Lewis-to-F344 rat chronic cardiac rejection model. Transplant. Proc. 27:2100-2104.
44. Saederup, N., Y. C. Lin, D. J. Dairaghi, T. J. Schall, and E. S. Mocarski. 1999. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. Proc. Natl. Acad. Sci. USA 96:10881-10886.
45. Söderberg-Naucler, C., K. Fish, and J. A. Nelson. 1997. Reactivation of human cytomegalovirus in a novel dendritic cell phenotype from healthy donors. Cell 91:119-126.
46. + monocytes is differentiation dependent. J. Virol. 75:7543-7554.
47. Speir, E., R. Modali, E. S. Huang, M. B. Leon, F. Shawl, T. Finkel, and S. E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265:391-394.
48. Steinhoff, G., X. M. You, C. Steinmuller, K. Boeke, F. S. Stals, C. A. Bruggeman, and A. Haverich. 1995. Induction of endothelial adhesion molecules by rat cytomegalovirus in allogeneic lung transplantation in the rat. Scand. J. Infect. Dis. Suppl. 99:58-60.
49. Streblow, D., C. Soderberg-Naucler, J. Vieira, P. Smith, E. Wakabayashi, F. Ruchti, K. Mattison, Y. Altschuler, and J. A. Nelson. 1999. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. Cell 99:511-520.
50. Tegtmeier, G. E. 1988. The use of cytomegalovirus-screened blood in neonates. Transfusion 28:201-203.
51. Thomas, E. D., R. Storb, R. A. Clift, A. Fefer, L. Johnson, P. E. Neiman, K. G. Lerner, H. Glucksberg, and C. D. Buckner. 1975. Bone-marrow transplantation. N. Engl. J. Med. 292:895-902.
52. Ustinov, J. A., T. T. Lahtinen, C. A. Bruggeman, P. J. Hayry, and I. T. Lautenschlager. 1994. Direct induction of class II molecules by cytomegalovirus in rat heart microvascular endothelial cells is inhibited by ganciclovir (DHPG). Transplantation 58:1027-1031.
53. Valantine, H. A., S. Z. Gao, G. Santosh, et al. 1999. Impact of prophylactic immediate post-transplant ganciclovir on development of transplant atherosclerosis. A post-hoc analysis of a randomized, placebo-controlled study. Circulation 100:61-66.
54. van Dorp, W. T., E. Jonges, C. A. Bruggeman, M. R. Daha, L. A. van Es, and F. J. van Der Woude. 1989. Direct induction of MHC class, I, but not class II, expression on endothelial cells by cytomegalovirus infection. Transplantation 48:469-472.
55. Vink, C., E. Beuken, and C. A. Bruggeman. 2000. Complete DNA sequence of the rat cytomegalovirus genome. J. Virol. 74:7656-7665.
56. Weller, T. H. 1971. The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. N. Engl. J. Med. 285:203-214.
57. Zhang, Z., L. Kaptanoglu, W. Haddad, D. Ivancic, Z. Alnadjim, S. Hurst, D. Tishler, A. D. Luster, T. A. Barrett, and J. Fryer. 2002. Donor T cell activation initiates small bowel allograft rejection through an IFN-gamma-inducible protein-10-dependent mechanism. J. Immunol. 168:3205-3212.